Novel microchip technology platform company

I was brought in to develop chromatin isolation protocols compatible with a novel microchip platform, including optimizing digestion and purification conditions for their specific chip chemistry. I also conducted application scoping to identify which scientific communities would find the most value in the technology and why.

Previous
Previous

Biotechnology company developing targeted drug delivery systems

Next
Next

Early-stage computational biology company